Press release
Market Trend Analysis: The Impact of Recent Innovations on the Drug and Gene Delivery Devices Market
Drug And Gene Delivery Devices Market
Future Market Size Projections for Drug and Gene Delivery Devices
The drug and gene delivery devices market is anticipated to grow substantially, reaching a valuation of $1.01 billion by 2030. This represents a compound annual growth rate (CAGR) of 8.6%. Several factors are propelling this growth, including advancements in viral and non-viral delivery vectors, the expanding application of personalized medicine and gene therapies, and increasing regulatory approvals of novel delivery technologies. Additionally, the rising uptake of nanomedicine and lipid nanoparticle (LNP) systems, combined with the integration of digital monitoring and smart delivery platforms, are key contributors to this upward trajectory. Important trends driving the market forward include the increased focus on targeted drug and gene therapies, the growing use of nanoparticle-based delivery methods, wider adoption of viral vectors for gene therapy, the spread of injectable and non-invasive delivery approaches, and ongoing innovations in controlled-release and personalized medicine technologies.
Download a free sample of the drug and gene delivery devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR
Emerging Companies Making an Impact in the Drug and Gene Delivery Devices Market
This market features a diverse roster of influential companies, including Medtronic plc, Moderna Inc., Halozyme Therapeutics Inc., Uniqure NV, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton dic*kinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation, ICU Medical, Stevanato Group, Gerresheimer AG, Ypsomed, and SHL Medical.
A notable development occurred in January 2025, when Switzerland-based pharmaceutical giant F. Hoffmann-La Roche Ltd acquired US-based Poseida Therapeutics Inc. for $1.5 billion. This strategic purchase aims to strengthen Roche's oncology pipeline and enhance its capabilities in allogeneic CAR-T cell therapies designed for treating blood cancers, solid tumors, and autoimmune diseases. Poseida Therapeutics specializes in complex immune cell therapies, particularly genetically engineered CAR-T treatments targeting cancer and autoimmune disorders.
Important Trends Shaping the Drug and Gene Delivery Devices Industry
Leading companies in the drug and gene delivery space are leveraging cutting-edge technologies such as artificial intelligence (AI) to sharpen their competitive edge. AI applications in drug delivery involve using sophisticated algorithms to boost the precision, effectiveness, and efficiency of therapeutic delivery systems.
For example, in December 2023, US-based Envoya Inc. introduced a novel gene therapy delivery platform that merges biopolymer-based nanoparticles with AI technology. This innovative solution addresses major challenges faced by current gene therapy modalities, including viral vectors and lipid nanoparticles, by improving safety profiles, increasing payload capacities, and enhancing tissue targeting capabilities.
View the full drug and gene delivery devices market report:
https://www.thebusinessresearchcompany.com/report/drug-and-gene-delivery-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR
Key Segments Defining the Drug and Gene Delivery Devices Market
The market report categorizes the drug and gene delivery devices industry into several key segments:
1) By Vector Type: Viral and Non-viral vectors
2) By Method of Delivery: In Situ and Ex Vivo techniques
3) By Route of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, and Topical routes
Further detailed segmentation includes:
- Viral vectors such as Adenovirus, Lentivirus, Adeno-Associated Virus (AAV), Herpes Simplex Virus (HSV), Retrovirus, Baculovirus, Vaccinia Virus, and Sendai Virus vectors
- Non-viral vectors including Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA delivery, Electroporation-based systems, Nanoparticle-based delivery systems, and Polymer Micelles and Hydrogels.
This comprehensive segmentation highlights the diversity and complexity within the drug and gene delivery devices market, underscoring the range of technologies and delivery methods that will influence its future growth.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Market Trend Analysis: The Impact of Recent Innovations on the Drug and Gene Delivery Devices Market here
News-ID: 4446704 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Overview of the Gastric Cancer Marke …
The gastric cancer market is poised for substantial expansion in the coming years, driven by significant advancements in medical technologies and growing awareness about early detection and treatment options. As the focus sharpens on personalized therapies and comprehensive cancer care, this sector is set to experience dynamic growth through 2030.
Projected Growth Trajectory of the Gastric Cancer Market
The size of the gastric cancer market is anticipated to increase rapidly, reaching…
Leading Companies Advancing Innovation and Growth in the Food Allergen Testing M …
The food allergen testing sector is poised for remarkable expansion as concerns about food safety and quality continue to rise worldwide. Increasingly stringent regulations, advancements in testing technology, and growing global food trade are all contributing to a surge in demand for precise and rapid allergen detection methods. Below, we delve into the market's size projections, key players, emerging trends, and segmentation to understand this fast-evolving industry better.
Projected Growth and…
Global Drivers Analysis: The Rapid Evolution of the Flow Cytometry Market in Onc …
An in-depth look at the flow cytometry market reveals substantial potential in oncology and immunology applications. This field is rapidly evolving, driven by breakthroughs in diagnostics and therapeutic approaches, setting the stage for significant market expansion in the coming years. Below is a detailed examination of the market size, key players, influential trends, and segmentation shaping this promising industry.
Projected Market Growth for Flow Cytometry in Oncology and Immunology
The flow…
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Fitn …
The fitness tracker market is set for significant expansion over the coming years, driven by technological advancements and growing consumer interest in health and wellness. As wearable technology becomes more sophisticated and integrated with AI, this sector is poised to experience remarkable growth through 2030. Here is an overview of the market size predictions, key players, emerging trends, and segmentation details shaping the future of the fitness tracker industry.
Projected Growth…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
